» Articles » PMID: 12578882

Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques of Apolipoprotein E-deficient Mice

Overview
Journal Circulation
Date 2003 Feb 13
PMID 12578882
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The role of infection in the development and complications of atherosclerosis has been the focus of much attention. We reported previously that influenza vaccination was associated with reduced risk of recurrent myocardial infarction. Here, we report the effect of influenza A virus on the apolipoprotein E-deficient (apoE(-/-)) mouse, an animal model of atherosclerosis.

Methods And Results: Twenty-four apoE(-/-) mice >24 months old were injected with 1 LD(50) (lethal dose 50) of influenza A virus. Ten wild-type C57BL/6 infected mice and 11 noninfected age-matched apoE(-/-) mice served as controls. Multiple aortic sections were studied histologically 3, 5, and 10 days later. The infected mice showed markedly increased intimal cellularity compared with the noninfected apoE(-/-) mice. No aortic abnormalities were seen in infected wild-type mice. Ten infected apoE(-/-) mice had a significant subendothelial infiltrate composed of a heterogeneous group of cells that stained positively for smooth muscle cell actin, F4/80 (macrophages), and CD3 (T lymphocytes). One case of subocclusive platelet and fibrin-rich thrombus was seen.

Conclusions: This study shows that influenza infection promotes inflammation, smooth muscle cell proliferation, and fibrin deposition in atherosclerotic plaques.

Citing Articles

Long term outcomes of patients with chronic kidney disease after COVID-19 in an urban population in the Bronx.

Lu J, Lu J, Wang S, Duong K, Henry S, Fisher M Sci Rep. 2025; 15(1):6119.

PMID: 39972044 PMC: 11839904. DOI: 10.1038/s41598-025-90153-6.


Influenza vaccine in cardiovascular disease: Current evidence and practice in India.

Roy A, Yadav S Indian Heart J. 2024; 76(6):365-369.

PMID: 39613096 PMC: 11705601. DOI: 10.1016/j.ihj.2024.11.247.


Immune mediators in heart-lung communication.

Gillan J, Jaeschke L, Kuebler W, Grune J Pflugers Arch. 2024; 477(1):17-30.

PMID: 39256247 PMC: 11711577. DOI: 10.1007/s00424-024-03013-z.


COVID-19 in the Initiation and Progression of Atherosclerosis: Pathophysiology During and Beyond the Acute Phase.

Chidambaram V, Kumar A, Sadaf M, Lu E, AlAref S, Tarun T JACC Adv. 2024; 3(8):101107.

PMID: 39113913 PMC: 11304887. DOI: 10.1016/j.jacadv.2024.101107.


Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study.

Cezard G, Denholm R, Knight R, Wei Y, Teece L, Toms R Nat Commun. 2024; 15(1):2173.

PMID: 38467603 PMC: 10928172. DOI: 10.1038/s41467-024-46497-0.